SCHEMBL5570286

SCHEMBL5570286

CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 9/20 0.47
PSMB1 P20618 1/20 0.44
PSMB5 P28074 1/20 0.44
PSMB2 P49721 1/20 0.44
ALDH1A1 P00352 2/20 0.42
CTSB P07858 7/20 0.40
CTSL P07711 1/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
KMT2A Q03164 1/20 0.40
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MMP14 P50281 1/20 0.38
CAPN9 O14815 1/20 0.38
MAPK1 P28482 1/20 0.38
MAPT P10636 1/20 0.38
LAP3 P28838 2/20 0.37
CTSK P43235 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29536183 1.00 CAPN1 (0.47) CAPN1PSMB1PSMB5PSMB2ALDH1A1
SCHEMBL25267609 0.98 CAPN1 (0.46) CAPN1PSMB1PSMB5PSMB2ALDH1A1
SCHEMBL15957011 0.98 CAPN1 (0.46) CAPN1PSMB1PSMB5PSMB2ALDH1A1
SCHEMBL5493312 0.86 ALDH1A1 (0.55) CAPN1PSMB1PSMB5PSMB2ALDH1A1
SCHEMBL5493308 0.86 ALDH1A1 (0.55) CAPN1PSMB1PSMB5PSMB2ALDH1A1
SCHEMBL3332680 0.85 CAPN1 (0.47) CAPN1PSMB1PSMB5PSMB2ALDH1A1
SCHEMBL13077059 0.85 CAPN1 (0.47) CAPN1PSMB1PSMB5PSMB2ALDH1A1
SCHEMBL9542347 0.85 ALDH1A1 (0.53) CAPN1PSMB1PSMB5PSMB2ALDH1A1
SCHEMBL16024738 0.85 CAPN1 (0.43) CAPN1PSMB1PSMB5PSMB2ALDH1A1
SCHEMBL24024845 0.85 CAPN1 (0.43) CAPN1PSMB1PSMB5PSMB2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070265208-A1 Association of calpain inhibitors and reactive oxygen species trapping agents SOCIETE DE CONSEILS DE RECHERCHE ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) 2007-11-15 US claimed
US-7244711-B2 Association of calpain inhibitors and reactive oxygen species trapping agents SOCIETE DE CONSEILS DE RECHERCHES ET D' 'APPLICATIONS SCIENTIFIQUES S.C.R.A.S (FR) 2007-07-17 US claimed
EP-1337269-B1 ASSOCIATION OF CALPAIN INHIBITORS AND REACTIVE OXYGEN SPECIES TRAPPING AGENTS SOD CONSEILS RECH APPLIC (FR) 2006-11-08 EP claimed
US-20040053851-A1 Association of calpain inhibitors and reactive oxygen species trapping agents IPSEN PHARMA S.A.S. (FR) 2004-03-18 US claimed
US-20070265208-A1 Association of calpain inhibitors and reactive oxygen species trapping agents SOCIETE DE CONSEILS DE RECHERCHE ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) 2007-11-15 US disclosed
US-7244711-B2 Association of calpain inhibitors and reactive oxygen species trapping agents SOCIETE DE CONSEILS DE RECHERCHES ET D' 'APPLICATIONS SCIENTIFIQUES S.C.R.A.S (FR) 2007-07-17 US disclosed
EP-1337269-B1 ASSOCIATION OF CALPAIN INHIBITORS AND REACTIVE OXYGEN SPECIES TRAPPING AGENTS SOD CONSEILS RECH APPLIC (FR) 2006-11-08 EP disclosed
US-20040053851-A1 Association of calpain inhibitors and reactive oxygen species trapping agents IPSEN PHARMA S.A.S. (FR) 2004-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265208-A1 Association of calpain inhibitors and reactive oxygen species trapping agents CAPNS1, CAPN1, CAPN2 CAPN1 2/4885PSMB1 116/4885PSMB5 313/4885
US-20040053851-A1 Association of calpain inhibitors and reactive oxygen species trapping agents CAPN2, CAPN1, CAPN9 CAPN1 2/4885PSMB1 219/4885PSMB5 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.